febuxostat has been researched along with gentamicin in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Risha, SE; Elsisi, AEE; Shalaby, MF; Sokar, SS | 1 |
1 other study(ies) available for febuxostat and gentamicin
| Article | Year |
|---|---|
Nephroprotective effects of febuxostat and/or mirtazapine against gentamicin-induced nephrotoxicity through modulation of ERK 1/2, NF-κB and MCP1.
Topics: Animals; Anti-Bacterial Agents; Antidepressive Agents; Chemokine CCL2; Drug Synergism; Febuxostat; Gentamicins; Gout Suppressants; Kidney Diseases; Male; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Rats | 2021 |